Maneuvering ofCS toward precision medicine for AML?
Abstract
microenvironments affects their expansion capacity and their response to ruxolitinib treatment.6 Thus, an in vitro model that recreates these microenvironments in a humanized context would enable detailed studies of their underlying cross talk and help identify therapeutic vulnerabilities.
Fields of Study & Subjects
Acute Myeloid Leukemia Research
Myeloproliferative Neoplasms: Diagnosis and Treatment
Chronic Myeloid Leukemia Treatments
Publication details
- Journal / source
- Blood
- Volume
- 147
- Issue
- 11
- Pages
- 1144–1145
- Publication date
- 12 March 2026
- Language
- EN